Preterm Infant Health
Advance human milk protein programs aimed at the hardest unmet needs in neonatal care, starting with preventing necrotizing enterocolitis and sepsis in preterm infants.
Biomilq Labs
Mammary Cell Biotechnology for Infant Health and Therapeutic Proteins
Building a new platform for human milk proteins, biologics development, and evidence-grounded execution.
Biomilq Labs is developing mammary-cell-based biotechnologies for high-value proteins and other molecules relevant to infant nutrition and therapeutic use. We pair that scientific platform with Mother Brain, an operating system for turning laboratory records into faster, better, and more traceable decisions.
Human milk proteinsTherapeutic protein platformSource-grounded operations
Platform
Three fronts, one integrated development engine.
Our public roadmap centers on molecules that matter biologically, manufacturing systems that can scale, and operating software that keeps every next step grounded in evidence.
Formula Ingredients
Produce high-value milk bioactives for next-generation infant nutrition with tighter quality control, stronger provenance, and scalable bioprocessing.
Therapeutic Protein Platform
Build a mammary-cell-based engine for producing proteins and other biologically relevant molecules across a broader set of clinical and commercial indications.
Why Mammary Cells
A production system aligned with the biology we care about.
Mammary biology is specialized for assembling a unique mixture of proteins, immune factors, and functional molecules that support infant development. We believe that matters when choosing how to design and manufacture the next generation of high-value milk-derived ingredients and therapeutics.
Better target selection
Focus on molecules with clear biological relevance, translational logic, and differentiated value.
Better process insight
Learn directly from experimental records, process outcomes, and prior decisions instead of losing them.
Mother Brain
An operating system for scientific memory, planning, and execution.
Mother Brain is the internal intelligence layer that organizes notebooks, scientific data, development plans, and operational context into a single working record. The first product surface is Notebook Intelligence: capture, organize, review, and summarize lab notebooks with full provenance.
01
Notebook and assay capture from mobile devices and laboratory records.
02
Structured extraction into experiments, protocols, proteins, materials, teams, and timelines.
03
Source-grounded retrieval for protocol drafting, development planning, grants, and IP.
04
Human-in-loop orchestration for approvals, retakes, escalations, and execution support.
Current build order
Notebook Intelligence first.
Capture pages, voice notes, and follow-up scans from iPhone. Organize them by notebook, page, author, and date. Then generate a source-cited brief with findings, open questions, and proposed next experiments.
Control model
- Evidence first. Every recommendation traces back to source records, experimental results, and dated decisions.
- Human sign-off. Scientific, legal, and purchasing actions stay behind approval gates with clear accountability.
- Cost-aware execution. Models, workflows, and experiments are routed with budget discipline from day one.
Public Direction
What this enables over time.
Scientific Copilot
Protocol drafting, experiment review, and bioprocess optimization grounded in historical records.
Funding Copilot
Grant discovery, tailored investor materials, diligence support, and continuous non-dilutive outreach.
IP Copilot
Invention capture, claim scaffolding, filing calendars, and traceable source support for patent work.
Global Ops Layer
Conference tracking, partner mapping, and country-specific operational support as programs mature.
Partners
We are building for collaborators who care about translational impact.
Biomilq Labs is interested in working with scientific, clinical, manufacturing, and financing partners who want to help move mammary-cell biotechnology into the real world with rigor.
Scientific collaborators working on neonatal, immunology, and protein development programs.
Manufacturing and translational partners for scalable bioprocessing and regulatory execution.
Investors, grant partners, and mission-aligned institutions helping accelerate the platform.